Last $5.69 USD
Change Today +0.29 / 5.37%
Volume 501.6K
NWBO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony E. Maida III, MA, MBA, Ph.D.

Senior Vice President of Clinical Research, Northwest Biotherapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 6 different organizations across 8 different industries.

See Board Relationships
61$300,000
As of Fiscal Year 2013

Background*

Dr. Anthony E. Maida, III, MA, MBA, Ph.D., has been Senior Vice President of Clinical Research at Northwest Biotherapeutics, Inc since 2014 and served as the Chief Operating Officer of Northwest Biotherapeutics, Inc. since June 11, 2011 until 2013. Dr. Maida is Principal of Anthony Maida Consulting International. He has been a Vice President of Clinical Research at PharmaNet Development Group, Inc. since August 2010. He is responsible for negotiating partnering and licensing ...

Read Full Background

Corporate Headquarters*

4800 Montgomery Lane
Bethesda, Maryland 20814

United States

Phone: 240-497-9024
Fax: --

Board Members Memberships*

Director
2003-Present
Independent Director, Chairman of Audit Committee, Member of Product Acquisition Committee and Member of Placement Committee
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2011-Present
Independent Director, Chairman of Audit Committee, Chairman of Clinical & Regulatory Affairs Committee and Member of Nominating & Corporate Governance Committee
2012-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

PhD 2010
University of California
BA 1975
Santa Clara University
MBA 1978
Santa Clara University
MA 1986
San Jose State University
BA 1977
San Jose State University

Other Affiliations*

Annual Compensation*

Salary$300,000
Total Annual Compensation$300,000

Stock Options*

Exercisable Options7,500
Unexercisable Options72,994
Total Number of Options80,494

Total Compensation*

Total Annual Cash Compensation$300,000
Total Short Term Compensation$300,000
Total Calculated Compensation$300,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NWBO:US $5.69 USD +0.29

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHWEST BIOTHERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.